This is our 7th year participating in Cycle for Survival. Our teams are dedicated to this important cause and have raised over $350k for rare cancer research. W're thrilled to be participating again. I was diagnosed in 2015 with a rare form of abdominal cancer. It's through novel treatments like those enabled through the research funded by Cycle for Survival that I am fortunate enough to continue to ride.
Please consider supporting our team as we ride to support this life saving research. It saves lives.
50% of People With Cancer Have a Rare Cancer
Around half of all people diagnosed with cancer have a rare form of the disease. Rare cancers include types you've likely heard of, such as leukemia and lymphoma, thyroid, ovarian, brain, and pancreatic cancer — and all pediatric cancers.
100% of Your Donation Supports Research
Every dollar you give goes directly to groundbreaking studies and clinical trials at MSK. As a world leader in cancer research, care, and education, MSK makes discoveries that have a far-reaching impact and revolutionize how cancer is diagnosed and treated worldwide.
6 Months for Fast Impact
Cycle for Survival not only provides much-needed resources but also makes sure that fundraising dollars get into the labs of MSK doctors and scientists fast. Within six months after fundraising ends, your donation will be helping researchers uncover insights about cancer that can lead to new and better treatments.
|The Cycle for Survival Web page and e-mail are provided as a courtesy to participants to help them manage fundraising efforts for this event. Memorial Sloan Kettering Cancer Center or any of its affiliated organizations, or their officers, directors, agents, or employees do not control, nor are they responsible for, the contents of this Web page. Any views or information provided on this Web page are the sole responsibility of the participant.
The participant's Web page may provide links to other Web sites and does not imply an endorsement by MSKCC, its affiliated organizations, their officers, directors, agents, and employees of the materials contained at those Web sites.